146 related articles for article (PubMed ID: 28977808)
1. In brief: Pancreatic enzyme replacement.
Med Lett Drugs Ther; 2017 Oct; 59(1531):170. PubMed ID: 28977808
[No Abstract] [Full Text] [Related]
2. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus.
Whitcomb DC; Bodhani A; Beckmann K; Sander-Struckmeier S; Liu S; Fuldeore M; Pollack PF; Khurmi RP
Pancreas; 2016; 45(5):679-86. PubMed ID: 26495784
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
[TBL] [Abstract][Full Text] [Related]
4. A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer.
Saito T; Nakai Y; Isayama H; Hirano K; Ishigaki K; Hakuta R; Takeda T; Saito K; Umefune G; Akiyama D; Watanabe T; Takagi K; Takahara N; Hamada T; Uchino R; Mizuno S; Mouri D; Yagioka H; Kogure H; Togawa O; Matsubara S; Ito Y; Yamamoto N; Tada M; Koike K
Pancreas; 2018 Aug; 47(7):800-806. PubMed ID: 29851751
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
Graff GR; McNamara J; Royall J; Caras S; Forssmann K
Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
[TBL] [Abstract][Full Text] [Related]
6. Challenges and Updates in the Management of Exocrine Pancreatic Insufficiency.
Hart PA; Conwell DL
Pancreas; 2016 Jan; 45(1):1-4. PubMed ID: 26658035
[No Abstract] [Full Text] [Related]
7. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.
Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L
Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic enzyme replacement therapy for enterally fed patients with cystic fibrosis.
Nicolo M; Stratton KW; Rooney W; Boullata J
Nutr Clin Pract; 2013 Aug; 28(4):485-9. PubMed ID: 23753650
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of pancreatic exocrine insufficiency.
Lindkvist B
World J Gastroenterol; 2013 Nov; 19(42):7258-66. PubMed ID: 24259956
[TBL] [Abstract][Full Text] [Related]
10. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis.
Taylor CJ; Thieroff-Ekerdt R; Shiff S; Magnus L; Fleming R; Gommoll C
J Cyst Fibros; 2016 Sep; 15(5):675-80. PubMed ID: 27013382
[TBL] [Abstract][Full Text] [Related]
12. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.
Roberts KJ; Schrem H; Hodson J; Angelico R; Dasari BVM; Coldham CA; Marudanayagam R; Sutcliffe RP; Muiesan P; Isaac J; Mirza DF
HPB (Oxford); 2017 Oct; 19(10):859-867. PubMed ID: 28711377
[TBL] [Abstract][Full Text] [Related]
13. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
[TBL] [Abstract][Full Text] [Related]
14. FDA approves third pancrelipase product: Unapproved products illegal to market after April 28.
Traynor K
Am J Health Syst Pharm; 2010 May; 67(10):776. PubMed ID: 20479094
[No Abstract] [Full Text] [Related]
15. The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
Knop FK; Vilsbøll T; Lund A; Krarup T; Holst JJ; Hornum M
JOP; 2010 Sep; 11(5):489-91. PubMed ID: 20818126
[No Abstract] [Full Text] [Related]
16. Effect of Pancrelipase Therapy on Exocrine Pancreatic Insufficiency Symptoms and Coefficient of Fat Absorption Associated With Chronic Pancreatitis.
Barkin JA; Barkin JS
Pancreas; 2021 Feb; 50(2):176-182. PubMed ID: 33560089
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic exocrine insufficiency in critically ill adult patients.
Ma L; Liu Y; Lu Z; Zhao L; Wang S
Panminerva Med; 2016 Mar; 58(1):78-85. PubMed ID: 26730461
[TBL] [Abstract][Full Text] [Related]
18. [Cholestasis and pancreatic insufficiency: how to start treatment?].
Gubergrits NB; Lukashevich GM
Eksp Klin Gastroenterol; 2014; (8):84-90. PubMed ID: 25911918
[TBL] [Abstract][Full Text] [Related]
19. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
20. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
Gubergrits N; Malecka-Panas E; Lehman GA; Vasileva G; Shen Y; Sander-Struckmeier S; Caras S; Whitcomb DC
Aliment Pharmacol Ther; 2011 May; 33(10):1152-61. PubMed ID: 21418260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
